Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Goslar

12 clinical trials in Goslar, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Goslar at a glance
12
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

12 trials in Goslar

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Elacestrant
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:GBG Forschungs GmbH

Cardiac failure

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Universitaetsklinikum Ulm AöR

Gout

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Universitaetsmedizin Greifswald KöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin Sulfate
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:WSG Women's Cancer Study Group GmbH

Neoplasm malignant

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:NSABP Foundation Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Hydroxycarbamide
  • Sponsor:Novartis Pharma GmbH

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Goslar

What the registry says about research in the country

01 Breast Cancer Research

Innovative clinical trials focusing on triple-negative breast cancer and HR+/HER2- breast cancer, evaluating new combination therapies and personalized treatment approaches.

  • Neoadjuvant chemotherapy with immunotherapy combinations
  • Targeted therapies for hormone receptor-positive disease
  • Novel treatment strategies for BRCA-mutated cancers

Studies aim to improve survival rates and treatment outcomes through precision medicine approaches.

02 Hematologic Oncology

Advanced research in blood cancers, including studies on Hodgkin Lymphoma and Chronic Lymphocytic Leukemia, testing innovative drug combinations.

  • Novel therapeutic regimens for lymphomas
  • Targeted treatments for high-risk CLL
  • Management of polycythemia vera

Investigations focus on reducing treatment toxicity while maintaining efficacy.

03 Gastrointestinal Oncology

Research examining treatment strategies for locally advanced rectal cancer, with emphasis on timing of interventions and surgical approaches.

  • Pre-surgical chemotherapy protocols
  • Risk-adapted treatment strategies
  • Disease-free survival optimization

Studies aim to improve surgical outcomes and reduce recurrence rates.

04 Inflammatory Conditions

Clinical investigations into the management of acute gout attacks, comparing different treatment approaches in primary care settings.

  • Comparative effectiveness of medications
  • Pain management strategies
  • Primary care interventions

Research focuses on optimizing treatment protocols for acute inflammatory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.